pamidronate has been researched along with SAPHO Syndrome in 17 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Pamidronate seems to be a very effective mode of therapy for patients with the SAPHO syndrome, by promoting remission in all components of the disorder, such as bone, joint and skin involvement, and ceases the bouts that characterize this disorder." | 9.11 | SAPHO syndrome treated with pamidronate: an open-label study of 10 patients. ( Aamar, S; Amital, H; Applbaum, YH; Daniel, N; Rubinow, A, 2004) |
| "Pamidronate has recently been used in SAPHO syndrome due to its anti-osteoclastic effect." | 7.73 | The usefulness of bone remodelling markers in predicting the efficacy of pamidronate treatment in SAPHO syndrome. ( Duquesnoy, B; Gerot, I; Grange, L; Puechal, X; Sibilia, J; Solau-Gervais, E; Sordet, C; Soubrier, M, 2006) |
| "To report the clinical experience with pamidronate in childhood SAPHO syndrome." | 7.72 | Pamidronate in the treatment of childhood SAPHO syndrome. ( Beresford, MW; Cleary, AG; Davidson, JE; Kerrison, C, 2004) |
| " Four of the five patients were able to reduce the dosage of their usual medications." | 5.31 | Pamidronate treatment in SAPHO syndrome. ( Guignard, S; Job-Deslandre, C; Kahan, A; Sayag-Boukris, V, 2002) |
| "Pamidronate seems to be a very effective mode of therapy for patients with the SAPHO syndrome, by promoting remission in all components of the disorder, such as bone, joint and skin involvement, and ceases the bouts that characterize this disorder." | 5.11 | SAPHO syndrome treated with pamidronate: an open-label study of 10 patients. ( Aamar, S; Amital, H; Applbaum, YH; Daniel, N; Rubinow, A, 2004) |
| " Common step 2-3 treatments were pamidronate, methotrexate, and TNF-a-inhibition (anti-TNFα), the latter two regarded especially convenient to co-target extra-skeletal inflammation in SAPHO syndrome." | 4.31 | Diagnostic and therapeutic practices in adult chronic nonbacterial osteomyelitis (CNO). ( Appelman-Dijkstra, NM; Clunie, G; Dekkers, OM; Koutrouba, E; Leerling, AT; Winter, EM, 2023) |
| "Pamidronate has recently been used in SAPHO syndrome due to its anti-osteoclastic effect." | 3.73 | The usefulness of bone remodelling markers in predicting the efficacy of pamidronate treatment in SAPHO syndrome. ( Duquesnoy, B; Gerot, I; Grange, L; Puechal, X; Sibilia, J; Solau-Gervais, E; Sordet, C; Soubrier, M, 2006) |
| "To report the clinical experience with pamidronate in childhood SAPHO syndrome." | 3.72 | Pamidronate in the treatment of childhood SAPHO syndrome. ( Beresford, MW; Cleary, AG; Davidson, JE; Kerrison, C, 2004) |
| "A FREQUENT AFFECTION: Ankylosing spondylitis is a chronic inflammatory rheumatism usually affecting young adults and characterized by an inflammatory enthesiopathy progressing towards ossification and ankylosis." | 2.42 | [Ankylosing spondylitis]. ( El Maghraoui, A, 2004) |
| "The acne was treated with isotretinoin." | 1.34 | [Back pain and acne conglobata: SAPHO syndrome]. ( Fehr, S; Kühn, F; Stoll, T, 2007) |
| " Four of the five patients were able to reduce the dosage of their usual medications." | 1.31 | Pamidronate treatment in SAPHO syndrome. ( Guignard, S; Job-Deslandre, C; Kahan, A; Sayag-Boukris, V, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 12 (70.59) | 29.6817 |
| 2010's | 3 (17.65) | 24.3611 |
| 2020's | 2 (11.76) | 2.80 |
| Authors | Studies |
|---|---|
| Leerling, AT | 1 |
| Clunie, G | 1 |
| Koutrouba, E | 1 |
| Dekkers, OM | 1 |
| Appelman-Dijkstra, NM | 1 |
| Winter, EM | 1 |
| You, H | 1 |
| Dang, G | 1 |
| Lu, B | 1 |
| Zhang, S | 1 |
| Li, C | 1 |
| Wang, L | 1 |
| Hu, Y | 1 |
| Chen, H | 1 |
| Zhang, J | 1 |
| He, W | 1 |
| Delattre, E | 1 |
| Guillot, X | 1 |
| Godfrin-Valnet, M | 1 |
| Prati, C | 1 |
| Wendling, D | 1 |
| Siau, K | 2 |
| Laversuch, CJ | 2 |
| Guignard, S | 1 |
| Job-Deslandre, C | 1 |
| Sayag-Boukris, V | 1 |
| Kahan, A | 1 |
| Courtney, PA | 1 |
| Hosking, DJ | 1 |
| Fairbairn, KJ | 1 |
| Deighton, CM | 1 |
| Crisp, AJ | 1 |
| Amital, H | 1 |
| Applbaum, YH | 1 |
| Aamar, S | 1 |
| Daniel, N | 1 |
| Rubinow, A | 1 |
| Kerrison, C | 1 |
| Davidson, JE | 1 |
| Cleary, AG | 1 |
| Beresford, MW | 1 |
| Valls-Roc, M | 1 |
| Sanmarti, M | 1 |
| Salles, M | 1 |
| Holgado, S | 1 |
| Olive, A | 1 |
| El Maghraoui, A | 1 |
| Solau-Gervais, E | 1 |
| Soubrier, M | 1 |
| Gerot, I | 1 |
| Grange, L | 1 |
| Puechal, X | 1 |
| Sordet, C | 1 |
| Sibilia, J | 1 |
| Duquesnoy, B | 1 |
| Hayem, G | 1 |
| Kühn, F | 1 |
| Fehr, S | 1 |
| Stoll, T | 1 |
| Van Doornum, S | 1 |
| Barraclough, D | 1 |
| McColl, G | 1 |
| Wicks, I | 1 |
| Marshall, H | 1 |
| Bromilow, J | 1 |
| Thomas, AL | 1 |
| Arden, NK | 1 |
3 reviews available for pamidronate and SAPHO Syndrome
| Article | Year |
|---|---|
SAPHO syndrome in an adult with ulcerative colitis responsive to intravenous pamidronate: a case report and review of the literature.
Topics: Acquired Hyperostosis Syndrome; Adult; Bone Density Conservation Agents; Colitis, Ulcerative; Diphos | 2010 |
[Ankylosing spondylitis].
Topics: Acquired Hyperostosis Syndrome; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; A | 2004 |
Valuable lessons from SAPHO syndrome.
Topics: Acquired Hyperostosis Syndrome; Animals; Antirheumatic Agents; Bone Density Conservation Agents; Dip | 2007 |
1 trial available for pamidronate and SAPHO Syndrome
| Article | Year |
|---|---|
SAPHO syndrome treated with pamidronate: an open-label study of 10 patients.
Topics: Acquired Hyperostosis Syndrome; Adult; Aged; Anti-Inflammatory Agents; Diphosphonates; Drug Administ | 2004 |
13 other studies available for pamidronate and SAPHO Syndrome
| Article | Year |
|---|---|
Diagnostic and therapeutic practices in adult chronic nonbacterial osteomyelitis (CNO).
Topics: Acquired Hyperostosis Syndrome; Adult; Child; Humans; Hyperostosis; Inflammation; Osteitis; Osteomye | 2023 |
Serum Sp17 Autoantibody Serves as a Potential Specific Biomarker in Patients with SAPHO Syndrome.
Topics: Acquired Hyperostosis Syndrome; Adult; Autoantibodies; Biomarkers; Bone and Bones; Bone Density Cons | 2021 |
SAPHO syndrome treatment with intravenous pamidronate. Retrospective study of 22 patients.
Topics: Acquired Hyperostosis Syndrome; Adult; Aged; Aged, 80 and over; Bone Density Conservation Agents; Di | 2014 |
SAPHO syndrome in an adult with ulcerative colitis responsive to intravenous pamidronate.
Topics: Acquired Hyperostosis Syndrome; Adult; Bone Density Conservation Agents; Colitis, Ulcerative; Diphos | 2010 |
Pamidronate treatment in SAPHO syndrome.
Topics: Acquired Hyperostosis Syndrome; Aged; Anti-Inflammatory Agents; Diphosphonates; Female; Follow-Up St | 2002 |
Treatment of SAPHO with pamidronate.
Topics: Acquired Hyperostosis Syndrome; Adult; Anti-Inflammatory Agents; Diphosphonates; Humans; Male; Pamid | 2002 |
Pamidronate for SAPHO syndrome.
Topics: Acquired Hyperostosis Syndrome; Anti-Inflammatory Agents; Diphosphonates; Humans; Pamidronate | 2003 |
Pamidronate in the treatment of childhood SAPHO syndrome.
Topics: Acquired Hyperostosis Syndrome; Adolescent; Anti-Inflammatory Agents; Child; Diphosphonates; Female; | 2004 |
SAPHO syndrome and pamidronate revisited.
Topics: Acquired Hyperostosis Syndrome; Adolescent; Adult; Anti-Inflammatory Agents; Diphosphonates; Female; | 2005 |
The usefulness of bone remodelling markers in predicting the efficacy of pamidronate treatment in SAPHO syndrome.
Topics: Acquired Hyperostosis Syndrome; Adolescent; Adult; Aged; Aged, 80 and over; Blood Sedimentation; Bon | 2006 |
[Back pain and acne conglobata: SAPHO syndrome].
Topics: Acne Vulgaris; Acquired Hyperostosis Syndrome; Administration, Oral; Administration, Topical; Adult; | 2007 |
SAPHO: rare or just not recognized?
Topics: Acquired Hyperostosis Syndrome; Adult; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Stero | 2000 |
Pamidronate: a novel treatment for the SAPHO syndrome?
Topics: Acquired Hyperostosis Syndrome; Anti-Inflammatory Agents; Diphosphonates; Female; Humans; Middle Age | 2002 |